title: Anasarca and hypertrophic cardiomyopathy in a liver transplant patient on FK506: relieved after a switch to Neoral.
authors.affiliation: Liver Unit, Rambam Medical Center, Technion, Haifa, Israel.
authors.forename: Y
authors.initials: Y
authors.lastname: Baruch
authors.forename: E
authors.initials: E
authors.lastname: Weitzman
authors.forename: W
authors.initials: W
authors.lastname: Markiewicz
authors.forename: A
authors.initials: A
authors.lastname: Eisenman
authors.forename: A
authors.initials: A
authors.lastname: Eid
authors.forename: R
authors.initials: R
authors.lastname: Enat
mesh_terms: D000284:Administration, Oral; D002312:Cardiomyopathy, Hypertrophic / Q000139:chemically induced* / Q000000981:diagnostic imaging; D016572:Cyclosporine / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D004452:Echocardiography; D004487:Edema / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology*; D008875:Middle Aged; D016559:Tacrolimus / Q000009:adverse effects*
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus